Ensign Group reports Q3 adjusted EPS $1.64, consensus $1.61

Reports Q3 revenue $1.3B, consensus $1.28B. “We are pleased to report another record quarter. The primary driver of these results is the extraordinary healthcare outcomes achieved by our dedicated and talented clinical teams. Simply put, our consistent financial results would not be possible without a relentless patient-focused culture that strives to deliver the highest quality clinical outcomes,” said Barry Port, Ensign’s Chief Executive Officer.